CLASS II ONGOING Drug recall · Reported 11 Nov 2026 · FDA Enforcement Report
Tirzepatide/B6 (MDV) 25MG/10MG/ML ****, VMC recalled
Victory Medical Center Pharmacy is recalling Tirzepatide/B6 (MDV) 25MG/10MG/ML ****, VMC, Victory Medical Center Pharmacy, Austin, distributed in Colorado, Florida, Texas. The recall was initiated on 19 Oct 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0148-2027
- FDA event ID
- 100168
- Recalling firm
- Victory Medical Center Pharmacy, Austin, TX
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 19 Oct 2026
- FDA classified
- 30 Oct 2026
- Reported
- 11 Nov 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Diabetes Medication
Timeline
| 19 Oct 2026 | Recall initiated by company | |
| 30 Oct 2026 | Classified by FDA | +11 days |
| 11 Nov 2026 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Processing Controls
Product as listed by the FDA
TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **8ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Where it was distributed
CO, FL, TX
Questions about this recall
Why was it recalled?
Lack of Processing Controls
Which lots are affected?
Lot, expiry: Lot 2012787 , exp 10/24/2026
Where was it sold?
CO, FL, TX
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
41 other products · FDA event 100168This product is part of a recall event; the main page for the event is Thymosin Alpha-1 (Mdv) 3MG/ML ****, Vmc recalled.
More recalls from Victory Medical Center Pharmacy
All 43| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methylcobalamin 5MG/ML (MDV) ****, VMC recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Semaglutide/L-carnitine 2.5/25MG/ML **** Mdv, Vmc recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Biotin 10MG/ML (MDV) ****, VMC recalled by Victory Medical Center | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | B Complex (MDV) ****, VMC, Victory Medical Center Pharmacy recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Electro B Complex (Mdv) ****, Vmc recalled by Victory Medical Center | Victory Medical Center Pharmacy | Other | CO, FL, TX |
Other Tirzepatide recalls
All 24| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide/L-carnitine 30/100MG/ML (Mdv) ****, Vmc recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Tirzepatide/L-carnitine (Mdv) 25/50MG/ML ****, Vmc recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Tirzepatide/L-carnitine (Mdv) 25/50MG/ML ****, Vmc recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Tirzepatide/L-carnitine (Mdv) 25/50MG/ML ****, Vmc recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |
| Drug | CLASS II | Tirzepatide/B6 (MDV) 25MG/10MG/ML ****, VMC recalled | Victory Medical Center Pharmacy | Other | CO, FL, TX |